CD24 and breast cancer: In the present study, we assessed the prognostic impact of CD24 expression in subgroups of breast cancer according to LN status or molecular subtypes to identify patients who can benefit from a therapy targeting CD24 and also investigated the regulatory mechanism of CD24 expression in breast cancer cells.